RecruitingNCT05729009

The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients


Sponsor

National Institute of Cardiology, Laranjeiras, Brazil

Enrollment

31 participants

Start Date

Oct 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying skin microvascular reactivity for people with heart transplantation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTskin microvascular reactivity

Laser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.


Locations(1)

Eduardo Tibiriçá

Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05729009


Related Trials